Core Insights - HEINEKEN inaugurated the Dr. H.P. Heineken Centre, a new €45 million Global Research and Development Centre in Zoeterwoude, Netherlands, aimed at enhancing brewing techniques and developing new beverages [1][7][11] - The Centre will focus on innovation in response to changing consumer preferences, including new flavors, natural ingredients, and low- or no-alcohol options [2][5] - The facility is strategically located near leading universities, fostering collaboration in sustainable brewing and fermentation science [6][8] Investment and Infrastructure - The Centre spans 8,800 m² and is designed to support HEINEKEN's global R&D network, which includes hubs in Mexico, South Africa, and Vietnam [11] - It will house around 100 employees from 12 nationalities, focusing on brewing innovation, flavor research, and sustainability [11] - The building meets BENG standards with an A++++ energy label, emphasizing HEINEKEN's commitment to sustainability [11] Strategic Goals - The Centre is part of HEINEKEN's EverGreen Strategy, aimed at innovating faster and smarter while reducing environmental impact [5] - It aims to connect HEINEKEN's brewing legacy with modern science, ensuring the development of products that resonate with future drinking cultures [5][7] - The investment reinforces the Netherlands' position in the global food technology sector and contributes to the knowledge economy through partnerships with universities [8]

尽管喜力啤酒在巴西的销量表现大致符合市场预期，但高盛认为，其定价同比持平的结果是一个负面惊 喜，这再次强化了该行对于竞争环境更加激烈、部分消费者转向低价品牌的看法。 智通财经APP获悉，高盛发布研报称，喜力啤酒于4月16日公布了其2025财年第一季度业绩。数据显 示，该公司在巴西市场的销量和销售额同比均出现了中个位数的下降，原因是去年的高基数影响。不 过，该公司管理层估计，从"售出"角度来看，其在该市场实现了份额增长。管理层特别指出主流产品线 表现强劲，其中Amstel品牌销量同比小幅增长。 因此，出于对竞争环境将更加激烈的预期，高盛重申对巴西啤酒巨头Ambev(ABEV.US)的"卖出"评级， 目标价为1.90美元，较4月16日收盘价2.33美元有超过18%的下跌空间。该行表示，尽管其认为喜力啤酒 的业绩不会改变市场对Ambev在巴西销量表现的预期，但在定价方面存在一定下行风险。Ambev计划于 5月8日公布财报。 资料显示，Ambev是拉丁美洲和加勒比地区最大的啤酒酿造商，也是百威英博在该地区的子公司。该公 司在巴西和其他拉丁美洲国家生产、分销和销售啤酒和百事公司产品，并拥有阿根廷最大的啤酒酿造商 Qui ...